登錄站點

用戶名

密碼

10 Unforgivable Sins Of Xarelto Lawsuit

已有 36 次閱讀  2017-11-07 15:06   標籤what  xarelto  prescribed  side  effects  joint  therapeutic 
Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to do so could be grounds for compensation. Our lawyers are operating tough to acquire those hurt by the drug the compensation they're entitled to.

xarelto effectsWhile bleeding is actually a common complication associated with anticoagulants, it has been alleged that Xarelto is far more hazardous than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, sufferers may possibly be at risk for irreversible bleeding troubles, like life-threatening internal and gastrointestinal hemorrhaging.

Should you or possibly a loved 1 suffered a severe bleeding occasion following taking Xarelto, you may have legal recourse. For more info, get in touch with us nowadays to have your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in situations of death, funeral expenditures. Furthermore, they may be seeking punitive damages, that are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior in the field of www.rechtopgezondheid.info anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.

Visit this page for more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
分享 舉報